{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:15:55Z","timestamp":1768295755187,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.eplepsyres.2012.05.004","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T16:17:28Z","timestamp":1338913048000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study"],"prefix":"10.1016","volume":"102","author":[{"given":"Romina","family":"Moavero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Cusmai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Specchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Curatolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Vigevano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nurt.2006.11.006","article-title":"Rufinamide","volume":"4","author":"Arroyo","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1167.2010.02729.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures","volume":"52","author":"Biton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0020","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1528-1167.2009.02160.x","article-title":"Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial","volume":"50","author":"Brodie","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.seizure.2010.09.008","article-title":"Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience","volume":"19","author":"Coppola","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-1331.2010.03113.x","article-title":"Rufinamide in refractory childhood epileptic encephalopathies other than Lennox-Gastaut syndrome","volume":"18","author":"Coppola","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eplepsyres.2009.12.003","article-title":"A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures","volume":"88","author":"Elger","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0040","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0031-1275346","article-title":"Epilepsy with myoclonic absences \u2013 favourable response to add-on rufinamide treatment in 3 cases","volume":"42","author":"Hausler","year":"2011","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.eplepsyres.2010.10.017","article-title":"Rufinamide for refractory epilepsy in a pediatric and young adult population","volume":"93","author":"Joseph","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0404.2010.01334.x","article-title":"Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study","volume":"122","author":"Kluger","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0060","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.yebeh.2010.01.005","article-title":"First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy","volume":"17","author":"Kluger","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0065","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yebeh.2011.04.057","article-title":"Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome","volume":"21","author":"Mueller","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.yebeh.2010.11.023","article-title":"Rufinamide for the treatment of epileptic spasms","volume":"20","author":"Olson","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-1211(00)00185-6","article-title":"Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy","volume":"43","author":"Palhagen","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","article-title":"Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy","volume":"49","author":"Perucca","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pediatrneurol.2010.04.003","article-title":"Experience with rufinamide in a pediatric population: a single center's experience","volume":"43","author":"Vendrame","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1684\/epd.2011.0406","article-title":"Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases","volume":"13","author":"Vendrame","year":"2011","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1277177","article-title":"Refractory focal epilepsy in a patient with methylmalonic aciduria: case report on positive and long-lasting effect of rufinamide","volume":"42","author":"von Stulpnagel","year":"2011","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/11586920-000000000-00000","article-title":"Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview","volume":"13","author":"Wier","year":"2011","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.eplepsyres.2012.05.004_bib0105","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1345\/aph.1M679","article-title":"Rufinamide: a new antiepileptic medication for the treatment of seizures associated with Lennox-Gastaut syndrome","volume":"44","author":"Wisniewski","year":"2010","journal-title":"Ann. Pharmacother."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:27:58Z","timestamp":1760275678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0920121112001374"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.05.004","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}